IdiomacatalàDeutschEnglishespañoleuskarafrançaisgalegoitalianoportuguêsromână
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Cornelia Eckert
Molecular variants, clonal evolution and clinical relevance in pediatric and adult T-cell lymphoblastic neoplasia
Abstract T-cell lymphoblastic lymphoma (T-LBL) and T-cell acute lymphoblastic leukemia (T-ALL) originate from thymic T-cell precursors, with ongoing debate on whether they are variants of the same disease or distinct entities. For 211 patients, including pediatric and adult T-ALL and T-LBL cases, targeted next-generation sequencing and SNP-arrays were performed, and single-nucleotide variants, indels and copy-number variants (CNVs) were analyzed.
Ultra-high-scale cytometry-based cellular interaction mapping - Nature Methods
Abstract Cellular interactions are of fundamental importance, orchestrating organismal development, tissue homeostasis and immunity. Recently, powerful methods that use single-cell genomic technologies to dissect physically interacting cells have been developed. However, these approaches are characterized by low cellular throughput, long processing times and high costs and are typically restricted to predefined cell types.
Role of stem-like cells in chemotherapy resistance and relapse in pediatric T-cell acute lymphoblastic leukemia - Nature Communications
Abstract T-ALL relapses are characterized by chemotherapy resistance, cellular diversity and dismal outcome. To gain a deeper understanding of the mechanisms underlying relapses, we conduct single-cell RNA sequencing on 13 matched pediatric T-ALL patient-derived samples at diagnosis and relapse, along with samples derived from 5 non-relapsing patients collected at diagnosis. This comprehensive longitudinal single-cell study in T-ALL reveals significant transcriptomic diversity.
Deutsche Medizinische Wochenschrift / Abstract
Die Lupus-Nephritis ist eine schwere Manifestation des Systemischen Lupus erythematodes, die bis zur Dialysepflicht führen kann. Zielgerichtete immunmodulierende Therapien und nephroprotektive Maßnahmen verbessern die renale Prognose und reduzieren die glukokortikoidassoziierte Toxizität. Studien belegen, dass Multi-Target-Therapien unter Einbezug von Calcineurin-Inhibitoren oder Belimumab einer Therapie mit Einzelsubstanzen überlegen sind.
Deutsche Medizinische Wochenschrift / Abstract
Die Untersuchung des Urins und deren (Be-)Wertung sind zentraler Bestandteil im diagnostischen Pfad von Nierenerkrankungen [1]. Essenziell sind dabei die korrekte Untersuchung und Interpretation des Urinsediments. Ein nephritisches Sediment weist mit hoher Spezifität auf eine glomeruläre Nierenerkrankung hin. Dieser Beitrag erläutert Befunderstellung, Bewertung und Konsequenzen eines nephritischen Sediments.
Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trials
Highlights • Paediatric high-risk relapsed B- and T-cell leukaemias have comparably poor outcomes. • Determinants of induction failure in high-risk B-cell relapses were identified. • Molecular good responders had better outcomes after stem cell transplantation. • Benchmarks for evaluation of novel immune or targeted therapies were provided.
Improving Stratification for Children With Late Bone Marrow B-Cell Acute Lymphoblastic Leukemia Relapses With Refined Response Classification and Integration of Genetics | Journal of Clinical Oncology
Cornelia Eckert, PhD1,2; Stefanie Groeneveld-Krentz, MSc1; Renate Kirschner-Schwabe, PhD1,2; Nikola Hagedorn, MD1; Christiane Chen-Santel, MD1; Peter Bader, MD3; Arndt Borkhardt, MD4; Gunnar Cario, MD5; Gabriele Escherich, MD6; Renate Panzer-Grümayer, MD7; Kathy Astrahantseff, PhD1; Angelika Eggert, MD1,2; Lucie Sramkova, MD, PhD8; Andishe Attarbaschi, MD7; Jean-Pierre Bourquin, PhD9; Christina Peters, MD7; Günter Henze, MD1; and Arend von Stackelberg, MD1 for the ALL-REZ BFM Trial Group Show...
PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia
Abstract Chromosomal rearrangements and specific aneuploidy patterns are initiating events and define subgroups in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Here we analyzed 250 BCP-ALL cases and identified a novel subgroup (‘PAX5-plus’, n = 19) by distinct DNA methylation and gene expression profiles. All patients in this subgroup harbored mutations in the B-lineage transcription factor PAX5, with p.P80R as hotspot.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Cornelia
Contact Cornelia, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack